177Lu-DOTATATE in neuroendocrine tumors: Real-world evidence of efficacy and safety in a community setting

被引：0
|
作者：
Sassic, Jessica
Farasat, Sadaf
Hermel, David
Sigal, Darren
Xavier, Marin Feldman
机构：
[1] Scripps Mercy Hosp, San Diego, CA USA
[2] Scripps Green Hosp, Scripps Clin, La Jolla, CA USA
[3] Scripps Clin, La Jolla, CA USA
[4] Scripps Clin, San Diego, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16249
引用
收藏
页数：1
相关论文
共 50 条
  • [31] NETTER-1 Phase III in Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-Dotatate: Efficacy and Safety Results
    Strosberg, Jonathan
    Wolin, Edward
    Chasen, Beth
    Kulke, Matthew
    Bushnell, David
    Caplin, Martin
    Baum, Richard
    Mittra, Erik
    Hobday, Timothy
    Hendifar, Andrew
    Oberg, Kjell
    Sierra, Maribel Lopera
    Kwekkeboom, Dik
    Ruszniewski, Philippe
    Krenning, Eric
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [32] NETTER-1 Phase III in Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-Dotatate: Efficacy and Safety Results
    Strosberg, J.
    Wolin, E.
    Chasen, B.
    Kulke, M.
    Bushnell, D.
    Caplin, M.
    Baum, R. P.
    Kunz, P.
    Hobday, T.
    Hendifar, A.
    Oberg, K.
    Sierra, M. Lopera
    Kwekkeboom, D.
    Ruszniewski, P.
    Krenning, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S121 - S121
  • [33] NETTER-1 Phase III in Patients with Midgut Neuroendocrine Tumors Treated with 177Lu-DOTATATE: Efficacy and Safety Results
    Strosberg, J.
    Wolin, E.
    Chasen, B.
    Kulke, M.
    Bushnell, D.
    Caplin, M.
    Baum, R.
    Kunz, P.
    Hobday, T.
    Hendifar, A.
    Oberg, K.
    Sierra, Lopera M.
    Kwekkeboom, D.
    Ruszniewski, P.
    Krenning, E.
    NEUROENDOCRINOLOGY, 2016, 103 : 95 - 95
  • [34] NETTER-1 phase III: efficacy and safety results in patients with midgut neuroendocrine tumors treated with 177Lu-dotatate
    Strosberg, J.
    Wolin, E.
    Chasen, B.
    Kulke, M.
    Bushnell, D.
    Chaplin, M.
    Baum, R.
    Kunz, P.
    Hobday, T.
    Oberg, K.
    Sierra, M. Lopera
    Kwekkeboom, D.
    Ruszniewski, P.
    Krenning, E.
    Hendifar, A.
    ANNALS OF ONCOLOGY, 2016, 27 : 121 - 121
  • [35] NETTER-1 phase III: Efficacy and safety results in patients with midgut neuroendocrine tumors treated with 177Lu-DOTATATE
    Strosberg, Jonathan R.
    Wolin, Edward M.
    Chasen, Beth
    Kulke, Matthew H.
    Bushnell, David L.
    Caplin, Martyn E.
    Baum, Richard P.
    Hobday, Timothy J.
    Hendifar, Andrew Eugene
    Oberg, Kjell E.
    Sierra, Maribel Lopera
    Kwekkeboom, Dik J.
    Ruszniewski, Philippe B.
    Krenning, Eric
    Kunz, Pamela L.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [36] 177-Lu-DOTATATE in 200 Patients with Neuroendocrine Tumors: Real-World Data from the SEPTRALU Registry
    Carmona-Bayonas, A.
    Mitjavila, Casanovas M.
    Bello, P.
    Percovich, J. C.
    Prieto, A.
    Arbizu, J.
    Field, C.
    Muro, M. A.
    Del Olmo, M. C.
    Castellon, M.
    Pubul, V
    Jimenez-Fonseca, P.
    NEUROENDOCRINOLOGY, 2020, 110 : 251 - 251
  • [37] Safety and Efficacy of 177Lu-DOTATATE in Children and Young Adult Population
    Aggarwal, Piyush
    Satapathy, Swayamjeet
    Sood, Ashwani
    Singh, Harmandeep
    Mittal, Bhagwant Rai
    Lal, Sadhna
    Gupta, Rajesh
    Das, Chandan Krushna
    Yadav, Thakur Deen
    Walia, Rama
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (07) : e312 - e318
  • [38] Real-world 177Lu-DOTATATE peptide receptor radionuclide therapy: Treatment outcomes with dosing variations and in non-midgut neuroendocrine tumors.
    Lee, Hwan
    Kipnis, Sarit
    O'Brien, Sophia
    Eads, Jennifer Rachel
    Katona, Bryson W.
    Pryma, Daniel A.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 593 - 593
  • [39] Resistant functioning and/or progressive symptomatic metastatic gastroenteropancreatic neuroendocrine tumors: efficacy of 177Lu-DOTATATE peptide receptor radionuclide therapy in this setting
    Kalshetty, Ashwini
    Ramaswamy, Anant
    Ostwal, Vikas
    Basu, Sandip
    NUCLEAR MEDICINE COMMUNICATIONS, 2018, 39 (12) : 1143 - 1149
  • [40] Treatment with the Radiolabelled Somatostatin Analog 177Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors
    Sansovini, Maddalena
    Severi, Stefano
    Ambrosetti, Alice
    Monti, Manuela
    Nanni, Oriana
    Sarnelli, Anna
    Bodei, Lisa
    Garaboldi, Lucia
    Bartolomei, Mirco
    Paganelli, Giovanni
    NEUROENDOCRINOLOGY, 2013, 97 (04) : 347 - 354
12345